By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Agenus (Formerly known as Antigenics Inc. - Lexington, MA) 

3 Forbes Road

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-721-3500 Fax: 781-938-6496



Company News
Agenus (AGEN) Completes $115 Million Non-Dilutive Royalty Transaction With Oberland Capital 9/9/2015 10:44:21 AM
Agenus (AGEN) Trades Away Future Royalties on Sales of GlaxoSmithKline (GSK) Drug for $115 Million 9/9/2015 5:51:47 AM
Agenus (AGEN) Reports Second Quarter 2015 Financial Results 7/23/2015 10:33:59 AM
Agenus (AGEN) To Report Second Quarter 2015 Financial Results On July 23, 2015; Conference Call To Follow 7/17/2015 7:35:39 AM
Agenus (AGEN) To Webcast Annual Meeting Of Stockholders 6/23/2015 1:22:13 PM
Agenus (AGEN) To Present At The 2015 JMP Securities Life Sciences Conference 6/19/2015 7:41:12 AM
Agenus (AGEN) Appoints C. Evan Ballantyne As Chief Financial Officer 6/17/2015 10:23:59 AM
Merck & Co. (MRK) Extends Immuno-Oncology Collaboration With Agenus (AGEN) 6/3/2015 8:53:22 AM
ASCO15: Agenus (AGEN) Release: Updated Phase 2 Data Of Prophage In Newly Diagnosed GBM Presented At ASCO Show Improvement In Median Progression Free Survival And Overall Survival Independently Of Prognostic Markers, Compared With Historical Expectations 6/1/2015 11:13:32 AM
Agenus (AGEN) Announces Closing Of Public Offering And Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock 5/28/2015 1:20:04 PM